Table 3.

Variably methylated regions (VMRs) where MD affected twins exhibited greater variance compared to MD unaffected twins and blood–brain correlations^a for CpGs within a VMR.

Chr	Start	End	Symbol	EntrezID	Number CpGs	Empirical AUC	Median Bl–Br Corr	Min Bl–Br Corr	Max Bl–Br Corr
chr3	39321449	39323539	CX3CR1b	1524	4	5572.92	0.67	−0.10	0.82
chr3	46925081	46925524	PTH1R	5745	2	5031.13	0.04	−0.12	0.19
chr3	170136920	170137321	CLDN11	5010	2	5110.24	−0.12	−0.45	0.22
chr6	32049516	32049825	NA	NA	3	5038.87	0.18	0.18	0.27
chr6	169284344	169287304	NA	NA	5	5276.01	0.27	−0.04	0.31
chr6	170595385	170597898	DLL1	28514	8	5628.62	0.38	0.16	0.61
chr7	157225062	157225567	NA	NA	2	5131.48	0.81	0.79	0.83
chr10	134739746	134741032	CFAP46	54777	4	5667.46	0.13	−0.30	0.16
chr11	64510112	64513156	RASGRP2	10235	7	5458.44	−0.12	−0.37	0.84
chr17	40837037	40839469	CNTNAP1	8506	4	5035.57	0.35	0.16	0.48

Bl blood, Br brain.

^aCorrelations were obtained from the ImageCpG database⁷².

^bMissing one CpG from ImageCpG database.